- Target
- GSDMD
- Reactivity
- Human
- Applications
- WB
- MW(Calculated)
- 53kD
- MW(Observed)
- 53kD
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate/Modification
- Unmodified
- Recommended Dilution Ratio
- WB 1:500-1:2000
- Formulation
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Purification
- The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
- Storage
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- 1 mg/ml
- Clonality
- Polyclonal
- Immunogen
- --
- Specificity
- The antibody detects endogenous full lenth and c-ternal fragment of gsdmd protein,
- Gene Name
- GSDMD
- Protein Name
- Gasdermin domain-containing protein 1,Gasdermin-D,GSDMD,GSDMD-CT,GSDMD-NT,GSDMD_HUMAN
- Other Name
- --
- Species
- Human
- Gene ID
- 79792
- Uniprot
- P57764
- Species
- --
- Gene ID
- --
- Uniprot
- --
- Species
- --
- Gene ID
- --
- Uniprot
- --
- Cellular Localization
- [Gasdermin-D]: Cytoplasm, cytosol . Inflammasome . In response to a canonical inflammasome stimulus, such as nigericin, recruited to NLRP3 inflammasone with similar kinetics to that of uncleaved CASP1 precursor. .; [Gasdermin-D, N-terminal]: Cell membrane; Multi-pass membrane protein . Secreted . Released in the extracellular milieu following pyroptosis. .; [Gasdermin-D, C-terminal]: Cytoplasm, cytosol .
- Tissue Expression
- Expressed in the suprabasal cells of esophagus, as well as in the isthmus/neck, pit, and gland of the stomach, suggesting preferential expression in differentiating cells.
- Signaling_pathway
- Organismal Systems >> Immune system >> Neutrophil extracellular trap formation;Organismal Systems >> Immune system >> NOD-like receptor signaling pathway;Organismal Systems >> Immune system >> Cytosolic DNA-sensing pathway
- Research Areas
- >>Neutrophil extracellular trap formation; / >>NOD-like receptor signaling pathway; / >>Salmonella infection
- Function
- Cleavage at Asp-275 by CASP1 (mature and uncleaved precursor forms), CASP4, CASP5 or CASP8 relieves autoinhibition and is sufficient to initiate pyroptosis (PubMed:26375003, PubMed:29898893, PubMed:32109412). Cleavage by CASP1 and CASP4 is not strictly dependent on the consensus cleavage site on GSDMD but depends on an exosite interface on CASP1 that recognizes and binds the Gasdermin-D, C-terminal (GSDMD-CT) part (PubMed:32109412). Cleavage by CASP8 takes place following inactivation of MAP3K7/TAK1 by Yersinia toxin YopJ (By similarity). Cleavage at Asp-87 by CASP3 or CAPS7 inactivates the ability to mediate pyroptosis (PubMed:28392147, PubMed:28045099).